Clinical features of Japanese male patients with type 1 autoimmune hepatitis

Alimentary Pharmacology and Therapeutics

Volumn 24, Issue 3, 2006, Pages 519-523

  Miyake, Y ^a,b   Iwasaki, Y ^b   Sakaguchi, K ^b   Shiratori, Y ^b  

^a Kurashiki Riverside Hospital   (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; CORTICOSTEROID; HLA DR4 ANTIGEN;

ADOLESCENT; ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; AUTOIMMUNE HEPATITIS; CLINICAL FEATURE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DIAGNOSTIC ACCURACY; DRUG RESPONSE; FEMALE; HUMAN; JAPAN; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCORING SYSTEM; SEX DIFFERENCE; SYMPTOM;

ADOLESCENT; ADULT; AGED; ALANINE TRANSAMINASE; ANTIBODIES; ANTIBODIES, ANTINUCLEAR; FEMALE; HEPATITIS, AUTOIMMUNE; HLA ANTIGENS; HUMANS; JAPAN; MALE; MIDDLE AGED; MUSCLE, SMOOTH;

EID: 33745896514     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2006.03013.x     Document Type: Article

References (13)

1. McFarlane IG. Definition and classification of autoimmune hepatitis. Semin Liver Dis 2002; 22: 317-24.
2. Krawitt EL. Autoimmune hepatitis. N Engl J Med 2006; 354: 54-66.
3. Czaja AJ. Treatment of autoimmune hepatitis. Semin Liver Dis 2002; 22: 365-78.
4. Alvarez F, Berg PA, Bianchi FB, et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999; 31: 929-38.
5. Czaja AJ, Donaldson PT. Gender effects and synergisms with histocompatibility leukocyte antigens in type 1 autoimmune hepatitis. Am J Gastroenterol 2002; 97: 2051-7.
6. Czaja AJ, Freese DK, American Association for the Study of Liver Disease. Diagnosis and treatment of autoimmune hepatitis. Hepatology 2002; 36: 479-97.
7. Toda G, Zeniya M, Watanabe F, et al. Present status of autoimmune hepatitis in Japan - correlating the characteristics with international criteria in an area with a high rate of HCV infection. Japanese National Study Group of Autoimmune Hepatitis. J Hepatol 1997; 26: 1207-12.
8. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 1994; 19: 1513-20.
9. McFarlane IG, Heneghan MA. Autoimmunity and the female liver. Hepatol Res 2004; 28: 171-6.
10. Buchel E, Van Steenbergen W, Nevens F, Fevery J. Improvement of autoimmune hepatitis during pregnancy followed by flare-up after delivery. Am J Gastroenterol 2002; 97: 3160-5.
11. Czaja AJ, Doherty DG, Donaldson PT. Genetic bases of autoimmune hepatitis. Dig Dis Sci 2002; 47: 2139-50.
12. Nakamura K, Yoneda M, Yokohama S, et al. Efficacy of ursodeoxycholic acid in Japanese patients with type 1 autoimmune hepatitis. J Gastroenterol Hepatol 1998; 13: 490-5.
13. Czaja AJ, Carpenter HA, Lindor KD. Ursodeoxycholic acid as adjunctive therapy for problematic type 1 autoimmune hepatitis: a randomized placebo-controlled treatment trial. Hepatology 1999; 30: 1381-6.